Answer from: Radiation Oncologist at Academic Institution
I agree with @Sushil Beriwal. In fact the medial portion of the contralateral breast (or chest wall if a contralateral mastectomy was pursued) may even be considered part of the clinical target volume if gross disease present at diagnosis actually extended past midline. Given the spread of inflammat...